Cargando…

Radical hysterectomy for FIGO stage I–IIB adenocarcinoma of the uterine cervix

A retrospective analysis was carried out to identify risk factors for survival and relapse in patients with FIGO stage I–IIB cervical adenocarcinoma (AC), who underwent radical hysterectomy, and to compare outcome and spread pattern with those of squamous cell carcinoma (SCC). One hundred and twenty...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kasamatsu, T, Onda, T, Sawada, M, Kato, T, Ikeda, S, Sasajima, Y, Tsuda, H
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2009
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2694432/ https://www.ncbi.nlm.nih.gov/pubmed/19401699 http://dx.doi.org/10.1038/sj.bjc.6605048

Ejemplares similares

Identifying selection criteria for non‐radical hysterectomy in FIGO stage IB cervical cancer
por: Kasamatsu, Takahiro, et al.
Publicado: (2019)

Radical hysterectomy with adjuvant radiotherapy versus radical radiotherapy for FIGO stage IIB cervical cancer
por: Chai, Yanlan, et al.
Publicado: (2014)

Cost-effectiveness of radical hysterectomy with adjuvant radiotherapy versus radical radiotherapy for FIGO stage IIB cervical cancer
por: Chai, Yanlan, et al.
Publicado: (2016)

Outcomes after radical hysterectomy in patients with early-stage adenocarcinoma of uterine cervix
por: Park, J-Y, et al.
Publicado: (2010)

Multivariate prognostic analysis of adenocarcinoma of the uterine cervix treated with radical hysterectomy and systematic lymphadenectomy
por: Kato, Tatsuya, et al.
Publicado: (2013)

Intraoperative radiotherapy in stage IIB adenocarcinoma of the uterine cervix: a retrospective study
por: Gao, Ying, et al.
Publicado: (2013)

Feasibility of radical hysterectomy in women with FIGO stage IIB cervical cancer: an observation study of 10-year experience in a tertiary center
por: Yuan, Lei, et al.
Publicado: (2018)

Prognostic Significance of DNA Cytometry in Carcinoma of the Uterine Cervix FIGO Stage IB and II
por: Grote, Hans Jürgen, et al.
Publicado: (2001)

Impact of age on morbidity and outcome of concurrent radiochemotherapy in high-risk FIGO stage I to IVA carcinoma of the uterine cervix following laparoscopic surgery
por: Laurentius, Thea, et al.
Publicado: (2010)

Vaginal Hysterectomy for Malignant Disease of the Cervix, and Uterine Myoma
por: McMurtry, L. S.
Publicado: (1894)

Data from small cell neuroendocrine carcinoma of the cervix: FIGO 2018 staging is more accurate than FIGO 2009
por: Zhang, Yunqiang, et al.
Publicado: (2022)

Radical Hysterectomy or Total Mesometrial Resection—Two Anatomical Concepts for Surgical Treatment of Cancer of the Uterine Cervix
por: Kostov, Stoyan, et al.
Publicado: (2023)

Association of preoperative conization with recurrences after laparoscopic radical hysterectomy for FIGO 2018 stage IB1 cervical cancer
por: Ding, Yan, et al.
Publicado: (2022)

Multidisciplinary perspectives on newly revised 2018 FIGO staging of cancer of the cervix uteri
por: Berek, Jonathan S., et al.
Publicado: (2018)

Risk model in stage IB1-IIB cervical cancer with positive node after radical hysterectomy
por: Chen, Zhilan, et al.
Publicado: (2016)

Clinical Analysis and Prognostic Prediction Model for Patients with Uterine Leiomyosarcoma at FIGO Stage I
por: Chen, Shuya, et al.
Publicado: (2023)

Chemoradiation with cisplatin followed by either brachytherapy or radical hysterectomy. A non-randomized comparison in FIGO stages IB2-IIA
por: Cetina, Lucely, et al.
Publicado: (2007)

The upper limit of optimal tumor size in patients with FIGO 2018 stage IB2 cervical cancer undergoing radical hysterectomy
por: Hwang, Woo Yeon, et al.
Publicado: (2020)

Laparoscopic or Open Radical Hysterectomy for Early Stage Cancer Cervix: Data Inconsistency of LACC Trial
por: Shekhar, Shashank, et al.
Publicado: (2019)

Imaging in Carcinoma Cervix and Revised 2018 FIGO Staging System: Implications in Radiology Reporting
por: Dhamija, Ekta, et al.
Publicado: (2021)

Prognostic factors and treatment of neuroendocrine tumors of the uterine cervix based on the FIGO 2018 staging system: a single-institution study of 172 patients
por: Chen, Jian, et al.
Publicado: (2021)

Ovarian preservation in adenocarcinoma of the uterine cervix
por: Zhou, Jiansong, et al.
Publicado: (2017)

The local treatment modalities in FIGO stage I‐II small‐cell carcinoma of the cervix are determined by disease stage and lymph node status
por: Zhou, Juan, et al.
Publicado: (2016)

The first case of recurrent small cell neuroendocrine carcinoma of the uterine cervix successfully treated with robotic-assisted super radical hysterectomy
por: Mabuchi, Seiji, et al.
Publicado: (2021)

Feasibility and outcome of total laparoscopic radical hysterectomy with no-look no-touch technique for FIGO IB1 cervical cancer
por: Kanao, Hiroyuki, et al.
Publicado: (2019)

Postoperative adjuvant radiation improves local control in surgically treated FIGO stage I-II small cell carcinoma of the cervix
por: Shen, Ting, et al.
Publicado: (2019)

The Prognostic Impact of Grading in FIGO IB and IIB Squamous Cell Cervical Carcinomas
por: Brambs, Christine E., et al.
Publicado: (2019)

Comparison of concurrent chemoradiotherapy followed by radical surgery and high-dose-rate intracavitary brachytherapy: a retrospective study of 240 patients with FIGO stage IIB cervical carcinoma
por: Wang, Ning, et al.
Publicado: (2014)

Sonographic and Histological Morphometry of the Uterine Cervix—An Assessment of Laparoscopic and Other lntrafascial Hysterectomy Techniques
por: Lehmann-Willenbrock, Enrique, et al.
Publicado: (1995)

The relationship between positive peritoneal cytology and the prognosis of patients with FIGO stage I/II uterine cervical cancer
por: Kuji, Shiho, et al.
Publicado: (2014)

Postoperative clinicopathological factors affecting cervical adenocarcinoma: Stages I–IIB
por: Zhou, Jiansong, et al.
Publicado: (2018)

Prognostic significance of the co-expression of EGFR and HER2 in adenocarcinoma of the uterine cervix
por: Ueda, Asako, et al.
Publicado: (2017)

Neoadjuvant chemotherapy using platinum- and taxane-based regimens for bulky stage Ib2 to IIb non-squamous cell carcinoma of the uterine cervix
por: Shoji, Tadahiro, et al.
Publicado: (2012)

Primary malignant melanoma of uterine cervix FIGO IIa1: A case report with 40 months ongoing survival and literature review()
por: Myriokefalitaki, E., et al.
Publicado: (2013)

Neoadjuvant Chemotherapy with Taxane and Platinum Followed by Radical Hysterectomy for Stage IB2-IIB Cervical Cancer: Impact of Histology Type on Survival
por: Matsuo, Koji, et al.
Publicado: (2019)

The safety of conization in the management of adenocarcinoma in situ of the uterine cervix
por: Kim, Mi-La, et al.
Publicado: (2011)

Comparison of adenocarcinoma and adenosquamous carcinoma prognoses in Chinese patients with FIGO stage IB-IIA cervical cancer following radical surgery
por: Zhang, Xiaojing, et al.
Publicado: (2020)

FIGO Staging for Uterine Sarcomas: Can the Revised 2008 Staging System Predict Survival Outcome Better?
por: Yim, Ga Won, et al.
Publicado: (2014)

Survival outcomes of abdominal radical hysterectomy, laparoscopic radical hysterectomy, robot-assisted radical hysterectomy and vaginal radical hysterectomy approaches for early-stage cervical cancer: a retrospective study
por: Zhang, Nina, et al.
Publicado: (2023)

Analysis of the effect of adjuvant radiotherapy on outcomes and complications after radical hysterectomy in FIGO stage IB1 cervical cancer patients with intermediate risk factors (GOTIC Study)
por: Nakamura, Kazuto, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_raivs26evi3ufscdirl1oksdhq